BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 25849622)

  • 1. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
    Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
    Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
    Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
    Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A and IL-17F stimulate chemokines via MAPK pathways (ERK1/2 and p38 but not JNK) in mouse cultured mesangial cells: synergy with TNF-alpha and IL-1beta.
    Iyoda M; Shibata T; Kawaguchi M; Hizawa N; Yamaoka T; Kokubu F; Akizawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F779-87. PubMed ID: 20042461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
    Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
    Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M and TLR-4 ligand synergize to induce MCP-1, IL-6, and VEGF in human aortic adventitial fibroblasts and smooth muscle cells.
    Schnittker D; Kwofie K; Ashkar A; Trigatti B; Richards CD
    Mediators Inflamm; 2013; 2013():317503. PubMed ID: 24307759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta.
    Faffe DS; Flynt L; Mellema M; Whitehead TR; Bourgeois K; Panettieri RA; Silverman ES; Shore SA
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1040-8. PubMed ID: 15665043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
    Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
    Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
    Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13.
    Faffe DS; Flynt L; Mellema M; Moore PE; Silverman ES; Subramaniam V; Jones MR; Mizgerd JP; Whitehead T; Imrich A; Panettieri RA; Shore SA
    J Allergy Clin Immunol; 2005 Mar; 115(3):514-20. PubMed ID: 15753898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
    Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
    Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice.
    Langdon C; Kerr C; Tong L; Richards CD
    J Immunol; 2003 Jan; 170(1):548-55. PubMed ID: 12496442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
    Repovic P; Mi K; Benveniste EN
    Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M modulates fibroblast function via signal transducers and activators of transcription proteins-3.
    Nagahama KY; Togo S; Holz O; Magnussen H; Liu X; Seyama K; Takahashi K; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):582-91. PubMed ID: 23668543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-17--induced interleukin-8 release in human airway smooth muscle cells: role for mitogen-activated kinases and nuclear factor-kappaB.
    Wuyts WA; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE; Demedts MG; Verleden GM
    J Heart Lung Transplant; 2005 Jul; 24(7):875-81. PubMed ID: 15982617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3'K and ERK1/2 MAPK signal transduction pathways.
    Smyth DC; Kerr C; Li Y; Tang D; Richards CD
    Cell Signal; 2008 Jun; 20(6):1142-50. PubMed ID: 18372159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C; Quaiser S; Pap T; Heinrich PC; Hermanns HM
    Arthritis Rheum; 2009 Jul; 60(7):1932-43. PubMed ID: 19565514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways implicated in oncostatin M-induced aggrecanase-1 and matrix metalloproteinase-13 expression in human articular chondrocytes.
    El Mabrouk M; Sylvester J; Zafarullah M
    Biochim Biophys Acta; 2007 Mar; 1773(3):309-20. PubMed ID: 17208315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.
    Migita K; Komori A; Torigoshi T; Maeda Y; Izumi Y; Jiuchi Y; Miyashita T; Nakamura M; Motokawa S; Ishibashi H
    Arthritis Res Ther; 2011 May; 13(3):R72. PubMed ID: 21548952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6.
    Fritz DK; Kerr C; Tong L; Smyth D; Richards CD
    J Immunol; 2006 Apr; 176(7):4352-60. PubMed ID: 16547273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
    Tong L; Smyth D; Kerr C; Catterall J; Richards CD
    Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.